Liver Disease
Conference Coverage
Interferon-free HCV-1 regimen scored high in patients co-infected with HIV
Key clinical point: An all-oral, interferon-free regimen for hepatitis C genotype 1 infection appeared to achieve a sustained virologic response...
News
Genotype 3 HCV linked to greater risk of cirrhosis, liver cancer
Key clinical point: Patients with genotype 3 hepatitis C virus infection are at significantly greater risk of developing cirrhosis and...
News
Fewer than 10% of HCV-infected patients complete treatment
Key clinical point: There are large gaps between current practice and treatment goals for patients with chronic HCV infection in the United States...
News
Fewer than 10% of HCV-infected patients complete treatment
Key clinical point: There are large gaps between current practice and treatment goals for patients with chronic HCV infection in the United States...
News
Everolimus fails to improve HCC survival
Key clinical point: Despite the "strong scientific rationale and preclinical data," everolimus failed to improve outcomes in advanced HCC. Major...
News
Nucleoside analogues’ benefits in HBV vary
Key clinical point: Entecavir treatment in HBV reduces the risk of transplant and death.Major finding: HBV patients treated with nucleoside...
Conference Coverage
Increased intestinal permeability is central to alcoholic hepatitis
Key clinical point: Endotoxins from gut bacteria may inflame the liver via increased intestinal permeability in alcoholic hepatitis.Major finding...
News
Medicare to cover hepatitis C screening
From the AGA Journals
Stop beta-blockers in spontaneous bacterial peritonitis
Major finding: Beta-blockers were linked to lower transplant-free survival among spontaneous bacterial peritonitis patients (hazard ratio, 1.58)....
Conference Coverage
Less risk of esophageal bleed with rifaximin
Key clinical point: Rifaximin may decrease the risk for esophageal variceal bleed in cirrhotic patients with medium to large esophageal varices....